Literature DB >> 2588473

Emergence from inhibited development of cyathostome larvae in ponies following failure to remove them by repeated treatments with benzimidazole compounds.

M Eysker1, J H Boersema, F N Kooyman.   

Abstract

The effect of three albendazole treatments at 5-week intervals, beginning at turnout in April, on cyathostome infections in Shetland ponies was compared with the effect of sequential treatments with albendazole, oxfendazole and oxibendazole. The results showed a substantial reduction in faecal egg output after the first albendazole treatment. Since faecal egg counts remained very low, no estimation of the effect of the second treatment was possible. The third treatment with albendazole and oxibendazole was followed by an increase in faecal egg counts to values of greater than 100 eggs g-1 within 4 weeks. A final albendazole treatment in December, 1 week before necropsy, failed to reduce faecal egg counts. These results suggest resistance to albendazole and oxibendazole in the cyathostome populations of the ponies. The increase in faecal egg counts after the third anthelmintic treatment in July occurred, although overwintered pasture infectivity was very low. The most likely explanation for this increase is resumption of the development of worms which overwintered as inhibited larvae in the host.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2588473     DOI: 10.1016/0304-4017(89)90168-4

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

1.  Equine cyathostomins: a review of biology, clinical significance and therapy.

Authors:  Susan Corning
Journal:  Parasit Vectors       Date:  2009-09-25       Impact factor: 3.876

2.  New method for simultaneous species-specific identification of equine strongyles (nematoda, strongylida) by reverse line blot hybridization.

Authors:  Donato Traversa; Raffaella Iorio; Thomas R Klei; Vitaliy A Kharchenko; Jakub Gawor; Domenico Otranto; Olivier A E Sparagano
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.